Bentyl and Gemzar drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Bentyl (dicyclomine hydrochloride) and Gemzar (gemcitabine hydrochloride). Common drug interactions include anhedonia among females and anorexia among males.

The phase IV clinical study analyzes what interactions people have when they take Bentyl and Gemzar. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Bentyl?

Bentyl has active ingredients of dicyclomine hydrochloride. It is often used in irritable bowel syndrome. eHealthMe is studying from 10,754 Bentyl users. Check the latest studies of Bentyl.

What is Gemzar?

Gemzar has active ingredients of gemcitabine hydrochloride. It is often used in pancreatic carcinoma. eHealthMe is studying from 20,315 Gemzar users. Check the latest studies of Gemzar.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 29, 2026

21 people who take Bentyl and Gemzar together, and have interactions are studied.

Bentyl and Gemzar drug interactions.

What are the common drug interactions of Bentyl and Gemzar, by gender? *:

female:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Osteomyelitis (infection of bone)
  3. Dyspnoea (difficult or laboured respiration)
  4. Anxiety
  5. Arthropathy
  6. Atelectasis (partial or complete collapse of the lung)
  7. Cervical spinal stenosis (narrowing of the spinal canal in the neck)
  8. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  9. Disability
  10. Dysuria (painful or difficult urination)

male:

  1. Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
  2. Dehydration (dryness resulting from the removal of water)
  3. Diarrhoea
  4. Nausea (feeling of having an urge to vomit)
  5. Pleural effusion (water on the lungs)
  6. Drug toxicity
  7. Oral intake reduced
  8. Vomiting

What are the common drug interactions of Bentyl and Gemzar, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Arthropathy
  4. Atelectasis (partial or complete collapse of the lung)
  5. Cervical spinal stenosis (narrowing of the spinal canal in the neck)
  6. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  7. Disability
  8. Dysuria (painful or difficult urination)
  9. Exostosis (formation of new bone on the surface of a bone)
  10. Hypokalaemia (low potassium)

60+:

  1. Pleural effusion (water on the lungs)
  2. Acute stress disorder
  3. Atelectasis (partial or complete collapse of the lung)
  4. Atrioventricular block first degree (heart block first degree)
  5. Blood glucose increased
  6. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  7. Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)
  8. Cardiac aneurysm (a condition that can occur after a myocardial infarction due to the inadequate resistance of the new scar tissue to the systolic pressure)
  9. Cerebral ischaemia (insufficient blood flow to the brain to meet metabolic demand)
  10. Cervical spinal stenosis (narrowing of the spinal canal in the neck)

What are the existing conditions these people have? *

  1. Pancreatic Carcinoma Metastatic (pancreatic cancer- metastatic): 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Bentyl and Gemzar?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Bentyl and Gemzar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Bentyl:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Gemzar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Bentyl and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Gemzar and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on dicyclomine hydrochloride and gemcitabine hydrochloride (the active ingredients of Bentyl and Gemzar, respectively), and Bentyl and Gemzar (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: